( 8 of 8 ) |
United States Patent | 7,041,814 |
Weinstock , et al. | May 9, 2006 |
The invention provides isolated polypeptide and nucleic acid sequences derived from Enterobacter cloacae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
Inventors: | Weinstock; Keith G. (Westborough, MA), Deloughery; Craig (Medford, MA), Bush; David (Somerville, MA) |
Assignee: |
Genome Therapeutics Corporation
(Waltham,
MA)
|
Appl. No.: | 09/252,691 |
Filed: | February 18, 1999 |
Application Number | Filing Date | Patent Number | Issue Date | ||
60094145 | Jul., 1998 | ||||
60074787 | Feb., 1998 | ||||
Current U.S. Class: | 536/24.1 ; 435/252.3; 435/320.1; 435/325; 435/4; 435/6; 435/69.1; 435/69.6; 536/23.1; 536/23.2; 536/23.5; 536/23.7 |
Current International Class: | C12Q 1/70 (20060101); C12Q 1/68 (20060101); C07H 21/04 (20060101) |
Field of Search: | 514/44 435/69.1,320.1,252.3,199,115,325,183,252.33,69.6,69.3,4,6 536/23.1,23.2,23.7,23.5,24.1 |
Boslego et al, Chapter 17, Gonorrhea Vaccines, Vaccines and immunotherapy, Pergamon Press, pp. 211-233, Edited by S. Cryz, Jr., 1991. cited by examiner . Orkin, S.H. et al, Dec. 7, 1995, Report and Recommendations of the Panel to Assess the NIH investment in research on gene therapy. cited by examiner . Lambert-Zechovsky, N et al, Clinical Infectious Diseases, Jul. 1992, vol. 15(1), pp. 30-32, (abstract). cited by examiner . Haertl, R et al, Journal of Clinical Microbiology, vol. 31(1), Jan. 1993, pp. 128-133, (abstract). cited by examiner . Matsutani, S, Journal of Bacteriology, vol. 173(24), pp. 7802-7809, Dec. 1991 (abstract). cited by examiner . Shryock, TR et al, Current Microbiology, vol. 14(5); pp. 251-254, (abstract only) 1987. cited by examiner . Mallea, M et al, FEMS Microbiology Letters, vol. 129(2-3), pp. 273-279, (abstract only) 1995. cited by examiner . Blattner et al, EMBL sequence alignment, created Jan. 29, 1997, Accession No. AE000213. cited by examiner . Oshima et al, EMBL sequence alignment, created Oct. 31, 1996, Accession No. ECD748. cited by examiner . Carter et al, WO96/641172, Database Accession No.: W10941, Dec. 19, 1996. cited by examiner . Blattner, et al, Science magazine, vol. 277(5331), pp. 1453-1474, 1997 (complete article). cited by examiner . Koonin, EV (1996), Nucleic acid Research, vol. 24(12), pp. 2411-2415. cited by examiner . Del Campo, M et al, RNA (2001), pp. 1603-1615, vol. 7. cited by examiner . Boslego, JW et al, Chapter 17, Gonorrhea vaccines, in Vaccines and Immunotherapy, p. 211-223. cited by examiner . Ellis, W; Chapter 29, New Technologies for Making Vaccines, p. 568-575, in Vaccines, WB Sunders Company, 1988. cited by examiner . Rattray et al, Applied and Environmental Microbiology, vol. 61(8), pp. 2950-2957, Aug. 1995. cited by examiner . French et al., Sequence and Properties of Pentaerythritol Tetranitrate Reductase from Enterobacter cloacae PB2, Journal of Biothecnology, Nov. 1996, p. 6623-6627. cited by other . Ehrhardt et al., Sequencing analysis of Four New Enterobacter ampD Allels, Antimicrobial Agents and Chemotherapy, Aug. 1996, p. 1953-1956. cited by other . Hou et al., Ribotyping and Random Amplification of Polymorphic DNA for Nosocomial Enterobacter cloacae Isolates in a Pediatric Intensive Care Unit, Concise Communications, vol. 18, No. 11, p. 769-771, Nov. 1997. cited by other . Deguchi et al., Detection of Mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae, Journal of Antimicrobial Chemotherapy, vol. 40, p. 543-549. cited by other. |